(BNS) Bank of Nova Scotia - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA0641491075

BNS: Banking, Investments, Mortgages, Loans, Insurance, Credit Cards

Bank of Nova Scotia, or Scotiabank, is a Canadian banking titan with operations spanning Canada, the U.S., Mexico, Peru, Chile, Colombia, the Caribbean, Central America, and beyond. This geographic diversity is a strategic strength, allowing the bank to navigate different economic cycles and tap into high-growth markets.

Scotiabanks business is divided into four main segments: Canadian Banking, International Banking, Global Wealth Management, and Global Banking and Markets. This structure allows the bank to cater to a wide range of clients, from individual consumers to large corporations, offering everything from basic chequing accounts to complex trade finance solutions.

For individual customers, Scotiabank provides the essentials: debit and credit cards, savings accounts, mortgages, loans, and insurance. But they also go beyond the basics, offering investment products like mutual funds, ETFs, and other wealth management services. Their approach to wealth management is particularly noteworthy, with a range of services that include online brokerage, trust services, and private banking.

On the business side, Scotiabank serves small, medium, and large businesses with lending, deposit, cash management, and trade finance solutions. This makes them a one-stop shop for businesses looking to manage their finances effectively. Their expertise in trade finance is especially valuable for companies operating across borders.

Founded in 1832 and headquartered in Toronto, Scotiabank has a long history of stability and growth. With a market cap of over $101 billion CAD, the bank is a major player in the financial industry. Its P/E ratio of 12.80 and forward P/E of 10.71 suggest that investors have confidence in its ability to generate future earnings.

Scotiabanks international presence is a key part of its strategy. By operating in both developed and emerging markets, the bank can balance stability with growth opportunities. This diversification helps mitigate risks and positions the bank well for long-term success.

Additional Sources for BNS Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

BNS Stock Overview

Market Cap in USD 59,456m
Sector Financial Services
Industry Banks - Diversified
GiC Sub-Industry Diversified Banks
IPO / Inception

BNS Stock Ratings

Growth 5y 55.5%
Fundamental 26.7%
Dividend 64.3%
Rel. Strength -13.5
Analysts -
Fair Price Momentum 65.39 CAD
Fair Price DCF 322.53 CAD

BNS Dividends

Dividend Yield 12m 4.63%
Yield on Cost 5y 8.13%
Annual Growth 5y 3.33%
Payout Consistency 89.1%

BNS Growth Ratios

Growth Correlation 3m -91.8%
Growth Correlation 12m 73.9%
Growth Correlation 5y 50.9%
CAGR 5y 11.80%
CAGR/Max DD 5y 0.36
Sharpe Ratio 12m 0.61
Alpha -3.05
Beta 1.020
Volatility 15.62%
Current Volume 11362.8k
Average Volume 20d 5066.8k
What is the price of BNS stocks?
As of April 01, 2025, the stock is trading at CAD 68.23 with a total of 11,362,766 shares traded.
Over the past week, the price has changed by -1.40%, over one month by -5.00%, over three months by -10.37% and over the past year by +4.47%.
Is Bank of Nova Scotia a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Bank of Nova Scotia is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 26.72 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BNS as of April 2025 is 65.39. This means that BNS is currently overvalued and has a potential downside of -4.16%.
Is BNS a buy, sell or hold?
Bank of Nova Scotia has no consensus analysts rating.
What are the forecast for BNS stock price target?
According to ValueRays Forecast Model, BNS Bank of Nova Scotia will be worth about 70.6 in April 2026. The stock is currently trading at 68.23. This means that the stock has a potential upside of +3.5%.
Issuer Forecast Upside
Wallstreet Target Price 79.2 16.1%
Analysts Target Price - -
ValueRay Target Price 70.6 3.5%